[A clinical analysis of benign prostatic hyperplasia with chronic prostatitis].
OBJECTIVE
To study the incidence of benign prostatic hyperplasia (BPH) complicated by chronic prostatitis.


METHODS
We performed routine examinations and bacterial culture of the expressed prostate secretion (EPS) for 213 cases of BPH, detected mycoplasma, chlamydia and serum PSA, and compared the results of IPSS of those complicated with chronic prostatitis before and after a 4-week anti-inflammatory treatment.


RESULTS
Of the total cases, 69 (32.4%) were complicated by chronic prostatitis, 27 (12.7%) EPS positive and 15 (7.0%) mycoplasma and chlamydia positive. Among the 69 cases of chronic prostatitis, 7 were found with an elevated level of PSA (> 4 microg/L), and 43 with the mean IPSS score decreased from (12.2 +/- 2.6) before anti-inflammatory treatment to (10.5 +/- 2.3) after it (P < 0.01).


CONCLUSIONS
EPS examination should be performed for patients with BPH, which is highly significant for the diagnosis of prostatitis, choice of medical or surgical treatment, improvement of therapeutic effect and reduction of complications.
Wu
Xue-jie
XJ
Department of Urology, the Second Xiangya Hospital, Central South University, Changsha, Hunan 410011, China. drwxj@sina.com
Yang
Luo-yan
LY
Zhang
Xuan-zhi
XZ
D000368:Aged; D000369:Aged, 80 and over; D002681:China / Q000453:epidemiology; D002689:Chlamydia / Q000302:isolation & purification; D002908:Chronic Disease; D006801:Humans; D015994:Incidence; D008297:Male; D008875:Middle Aged; D009174:Mycoplasma / Q000302:isolation & purification; D011467:Prostate / Q000187:drug effects / Q000382:microbiology / Q000473:pathology; D017430:Prostate-Specific Antigen / Q000097:blood; D011470:Prostatic Hyperplasia / Q000150:complications / Q000188:drug therapy / Q000453:epidemiology*; D011472:Prostatitis / Q000097:blood / Q000150:complications* / Q000382:microbiology
D017430:Prostate-Specific Antigen